MRNA · 8-K · 20260901PR378505

Capped Call Transactions

Moderna, Inc. · 2026-09-01 · Importance 34 · Surprise 42

Moderna expects to enter into privately negotiated capped call transactions covering the shares initially underlying the notes. The transactions are intended to reduce potential dilution upon conversion and/or offset cash payments above the notes’ principal amount, subject to a cap. Moderna anticipates that the cap price will initially be at least 150% above the common stock’s last reported sale price on the offering’s pricing date, and would use part of proceeds from any additional notes to enter into additional capped calls.

Key facts